Psyence Biomedical (PBM) Competitors $3.72 -0.07 (-1.85%) Closing price 09/17/2025 04:00 PM EasternExtended Trading$4.62 +0.90 (+24.30%) As of 08:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PBM vs. ALVR, NNVC, PMN, PASG, FBLG, PRPH, SONN, LIXT, QTTB, and TAOXShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include AlloVir (ALVR), NanoViricides (NNVC), Promis Neurosciences (PMN), Passage Bio (PASG), FibroBiologics (FBLG), ProPhase Labs (PRPH), Sonnet BioTherapeutics (SONN), Lixte Biotechnology (LIXT), Q32 Bio (QTTB), and Synaptogenix (TAOX). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. Its Competitors AlloVir NanoViricides Promis Neurosciences Passage Bio FibroBiologics ProPhase Labs Sonnet BioTherapeutics Lixte Biotechnology Q32 Bio Synaptogenix AlloVir (NASDAQ:ALVR) and Psyence Biomedical (NASDAQ:PBM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Does the media favor ALVR or PBM? In the previous week, AlloVir's average media sentiment score of 0.00 equaled Psyence Biomedical'saverage media sentiment score. Company Overall Sentiment AlloVir Neutral Psyence Biomedical Neutral Which has better valuation and earnings, ALVR or PBM? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlloVirN/AN/A-$190.42M-$20.23-0.25Psyence BiomedicalN/AN/A$1.01MN/AN/A Which has more volatility and risk, ALVR or PBM? AlloVir has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Comparatively, Psyence Biomedical has a beta of 0.18, suggesting that its share price is 82% less volatile than the S&P 500. Is ALVR or PBM more profitable? Psyence Biomedical's return on equity of 0.00% beat AlloVir's return on equity.Company Net Margins Return on Equity Return on Assets AlloVirN/A -71.03% -61.27% Psyence Biomedical N/A N/A N/A Do institutionals & insiders believe in ALVR or PBM? 66.1% of AlloVir shares are owned by institutional investors. Comparatively, 77.4% of Psyence Biomedical shares are owned by institutional investors. 32.1% of AlloVir shares are owned by company insiders. Comparatively, 3.6% of Psyence Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryPsyence Biomedical beats AlloVir on 4 of the 6 factors compared between the two stocks. Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PBM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBM vs. The Competition Export to ExcelMetricPsyence BiomedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.08M$3.12B$5.74B$10.30BDividend YieldN/A2.37%5.86%4.62%P/E RatioN/A21.0376.8726.52Price / SalesN/A249.02448.2587.93Price / Cash2.1245.4837.2260.63Price / Book0.319.5613.846.31Net Income$1.01M-$53.02M$3.29B$271.37M7 Day Performance14.81%-1.58%-0.76%0.57%1 Month Performance12.73%2.82%3.83%6.20%1 Year Performance-95.52%9.34%84.84%28.33% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMPsyence Biomedical0.1872 of 5 stars$3.72-1.8%N/A-95.0%$7.08MN/A0.00N/APositive NewsGap UpALVRAlloVirN/A$4.68+0.9%N/A-71.0%$23.60MN/A-0.23110Gap UpHigh Trading VolumeNNVCNanoViricides0.1424 of 5 stars$1.45-1.0%N/A-9.4%$23.22MN/A-2.0120Gap UpPMNPromis Neurosciences3.6795 of 5 stars$0.44+4.0%$4.33+889.3%-65.3%$22.64MN/A-2.085Positive NewsShort Interest ↓PASGPassage Bio4.0995 of 5 stars$7.11+1.6%$75.67+964.2%-51.7%$22.60MN/A-0.39130Insider TradeFBLGFibroBiologics3.2454 of 5 stars$0.54-0.2%$13.00+2,320.9%-83.9%$22.50MN/A-1.4910PRPHProPhase Labs1.0257 of 5 stars$0.54+5.0%N/A-83.9%$22.43M$6.77M-0.43130SONNSonnet BioTherapeutics2.8952 of 5 stars$3.25+4.1%$20.00+515.6%-7.2%$22.15M$1M0.0010Gap UpLIXTLixte Biotechnology0.872 of 5 stars$4.84+0.7%N/A+163.1%$22.12MN/A-3.764QTTBQ32 Bio2.6281 of 5 stars$1.79+0.6%$12.17+579.7%-96.3%$21.71MN/A-0.4139TAOXSynaptogenix0.1648 of 5 stars$6.21-0.5%N/AN/A$21.67MN/A-0.314 Related Companies and Tools Related Companies AlloVir Alternatives NanoViricides Alternatives Promis Neurosciences Alternatives Passage Bio Alternatives FibroBiologics Alternatives ProPhase Labs Alternatives Sonnet BioTherapeutics Alternatives Lixte Biotechnology Alternatives Q32 Bio Alternatives Synaptogenix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PBM) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBM Stock Alerts